به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت
جستجوی مقالات مرتبط با کلیدواژه

rotavirus vaccine

در نشریات گروه پزشکی
تکرار جستجوی کلیدواژه rotavirus vaccine در مقالات مجلات علمی
  • عسگر آقایی هشجین، مهدی صحرایی*
    زمینه و هدف

    روتاویروس شایع ترین علت بیماری اسهالی در کودکان سراسر جهان است. واکسیناسیون کودکان تاثیر بسیار مهمی در کاهش عفونت اسهالی دارد. مطالعه حاضر با هدف تعیین ایمنی و اثربخشی واکسن روتاویروس اجرا شده است.

    روش کار

    مطالعه به روش مرور نظام مند و متاآنالیز انجام شده است. پایگاه های اطلاعاتی Iranmedex, Nirp, SID, Web of science, Scopus, CRD, Pubmed, Magiran, Cochrane,  و موتور جستجوگر Google scholar بین سال های 2000 تا 2019 جستجو گردید. معیارهای ورود مطالعه ، کودکان کمتر از 5 سال، مداخلات با انواع واکسن Rotavirus vaccine در مقایسه با دارونما یا عدم استفاده از واکسن در نظر گرفته شد. تمام مطالعات مداخله ای، پس از ارزیابی کیفیت متدولوژی وارد مطالعه شدند. اثر نهایی کل با برآورد خطای استاندارد و نسبت از طریق متاآنالیز با شیوه ی مدل تصادفی برآورد گردید و سپس کارایی واکسن محاسبه شد. تورش انتشار مطالعات آن با آزمون های مربوط ارزیابی شد.

    نتایج

    با مرورسیستماتیک 767 مقاله مرتبط جستجو شد. سپس با مطالعه متن کامل 61 مقاله و غربال شدن 18 مقاله بر اساس پیامدهای کاهش ویزیت، کاهش بستری در بیمارستان و مرگ شش مطالعه در نهایت انتخاب شدند.
    برآورد اثربخشی کلی واکسن  RQبا شاخص خطای استاندارد و  RXبا شاخص نسبت اثربخشی به ترتیب 94% و 79% و نسبت خطر در گروه مورد به شاهد (96/41-81/23) محاسبه شده است.

    نتیجه گیری

    یافته های این مطالعه، اثربخشی بالای این واکسن در کاهش اسهال روتاویروس را تایید کرد. در نتیجه بار اقتصادی قابل انتساب به این بیماری کاهش قابل توجهی خواهد داشت.

    کلید واژگان: واکسن، روتاویروس، کودکان
    Aghaei Hashjin, M.Sahraei *
    Background and Aim

    Rotavirus is the most common cause of diarrhea in children worldwide. Vaccination of children has a very important effect in reducing diarrheal infection. This study was conducted to determine the safety and effectiveness of a rotavirus vaccine in children.

    Materials and Methods

    This study was a systematic review and meta-analysis, the data bases searched being Iranmedex, Nirp, SID, Web of science, Scopus, CRD, Pubmed, Magiran, Cochrane, and Google scholar search engine between 2000 and 2019. The inclusion criteria were children under 5 years of age, interventions with the rotavirus vaccines, Rota Teq or RV1 or RV5 or RRV or RRVTV or Rotarix or RIX-4414, compared with placebo or no vaccine. All the intervention studies were, after evaluating the quality of the methodology, included in the study. The total final effect was estimated by estimating the standard error and the ratio through meta-analysis using a random model method, followed by calculating the vaccine effectiveness. The publication bias of the studies was evaluated using the relevant tests.

    Results

    A total of 767 related articles were searched by systematic review, followed by studying the full texts of 61 articles and screening 18 based on the consequences resulting from reduced visits, reduced hospitalizations and deaths, and selecting finally six studies. The overall efficiencies of the Rotateq vaccine and Rotarix were estimated, based on the standard error index and the efficacy ratio index, to be 94% and 79%, respectively, and the risk ratio (case group to the control group) was 23.81-41.96.

    Conclusion

    The findings of this study confirm the high effectiveness of the rotavirus vaccine in reducing rotavirus diarrhea. This means that the economic burden attributable to this disease will be significantly reduced.

    Keywords: Vaccine, Rotavirus Vaccine, Children
  • Salem ALKOSHI*, Eyal LESHEM
    Background

    There are little data on the current condition of national immunization programme (NIP) in Libya. In 2013, pentavalent rotavirus vaccines were added to the NIP. Incomplete rotavirus vaccine series may result in lower vaccine effectiveness. The study aimed to assess timeliness and coverage rates of routine NIP vaccinations including the newly introduced rotavirus vaccine in Libya.

    Methods

    A prospective cross-sectional study of children aged 0 to 18 months was carried out in vaccination centers of two north-western cities. Data were collected during Nov-Dec 2016 from vaccination cards of children. Child age and doses received in previous visits were documented.

    Results

    Overall, we included 1023 children assessed in 29 visits at six vaccination centers. In children aged 18 months, coverage rates for all doses of BCG, OPV, HepB, pneumococcal, Meningococcal and MMR vaccines exceeded 95%. Coverage rates for second and third doses of rotavirus vaccines were 89% and 68%, respectively. Most (75%) children who missed the third dose of rotavirus vaccine were aged >8 months when at the time of appointment for the third dose.

    Conclusion

    Overall, the coverage rate for routine vaccination in children assessed at immunization centers in northwest Libya was high. Lower coverage of full pentavalent rotavirus vaccine series may have been the result of exceeding the age restriction. Measures to improve timeliness of vaccination appointments should be assessed. Lifting the age restriction on rotavirus vaccines should be considered for at-risk population.

    Keywords: Routine vaccination, Coverage rate, Rotavirus vaccine, Age restrictions, Libya
  • Abdoulreza Esteghamati, Mohammadamin Joulani, Shirin Sayyahfar*, Sarvenaz Salahi, Mahla Babaie, AhmadReza Shamshiri, Alireza Fahimzad
    Background

    The aim of this study was to determine the baseline statistics of intussusception in the under-five- year age group in Iran to facilitate the monitoring of potential side effects after administration of rotavirus vaccine.

    Methods

    This hospital-based historical cohort study reviewed children under 60 months of age with the final diagnosis of intussusception, ICD-10 code K56.1, using census in all hospitals of Tehran, Iran from March 2010-2015. Demographic (sex, age, hospital stay duration), clinical manifestations (such as currant jelly stool, abdominal pain, vomiting, and fever),diagnostic and treatment methods (contrast enema, ultrasonography, laparotomy, and laparoscopy), and outcome data of patients aged less than 5 years with the diagnosis of intussusception were collected and analyzed using SPSS Version 16.0 (SPSS Inc., Chicago, IL, USA)

    Results

    In this study, 759 patients were diagnosed with intussusception; 309 (40.7%) cases were less than 12 months old. The annual incidence of intussusception was 66.54 cases per 100.000 in children less than one-year-old and 31.61 cases per 100.000 in children less than five years old. The most common symptoms and signs were abdominal pain/irritability (94.2%) and tenderness (24.2%), respectively. The diagnostic method was ultrasound in 75.9% of cases. The most frequent anatomic location was the ileocolic region (87.87%) and the most common treatment method was barium enema.

    Conclusion

    This research has provided a baseline statistic for childhood intussusception in Tehran prior to the administration of the rotavirus vaccine to provide a better comparison with post-introduction data.

    Keywords: Incidence, Intussusception, Invagination, Pediatrics, Rotavirus vaccine
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال